Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Rat dog micro-cap picks... -- Ignore unavailable to you. Want to Upgrade?

To: longnshort who wrote (14847)	10/23/2003 11:05:14 AM
From: tsigprofit	Respond to of 48461

How many US soldiers have been killed in Bosnia? Bosnia is on the edge of Europe - and NATO is there with us - completely different situation. And - I think we need to transition out of there also. It's not a Democrat/Republican issue.

To: longnshort who wrote (14847)	10/23/2003 11:11:43 AM
From: Bucky Katt	Read Replies (1) \| Respond to of 48461

Hey buddy, we are still in Japan, Germany, Korea and all the rest! I sense a paradigm shift coming down the road..

To: longnshort who wrote (14847)	10/23/2003 11:36:20 AM
From: Bucky Katt	Read Replies (1) \| Respond to of 48461

Clinton Program Would Help Poor Nations Get AIDS Drugs By MARK SCHOOFS Staff Reporter of THE WALL STREET JOURNAL Former President Bill Clinton plans to announce Thursday a landmark program that attacks two of the toughest obstacles to treating AIDS in the developing world: high drug prices and low-quality health infrastructures. The Clinton Foundation HIV/AIDS Initiative has clinched a deal with four generic-drug companies, including one in South Africa, to slash the price of antiretroviral AIDS medicine. Engineered by longtime Clinton adviser Ira Magaziner, the agreement will cut the price of a commonly used triple-drug regimen by almost a third, to about 38 cents a day per patient from an already cut-rate generic price of about 55 cents. The lowest available price for the same regimen using patented versions of the drugs in developing nations is $1.54. For a key drug, nevirapine, the price will be cut by almost half. The agreement also establishes a way of working that is rare in the secretive pharmaceutical industry. The companies involved -- Ranbaxy Laboratories Ltd., Cipla Ltd. and Matrix Laboratories Ltd., all of India, and the South African company Aspen Pharmacare Holdings Ltd. -- opened their books and manufacturing processes to a group of Clinton business advisers. Then the advisers and the companies hunted for ways to cut costs, starting with raw-material suppliers in China and ending with the products' packaging. Mr. Clinton's team plans to use this approach to try to lower the price of diagnostic tests, which are still very expensive. Under the supervision of Mr. Magaziner, the Clinton Foundation HIV/AIDS Initiative also helped several Caribbean states and three African countries prepare detailed government-approved plans for rolling out the drugs nationwide, instead of just in selected regions. The plans aim to improve the entire health-care system by preparing budgets for hiring and training nurses and doctors, building and upgrading laboratories and clinics, developing patient-information systems, and improving drug warehousing and delivery. Only a handful of other sub-Saharan countries, such as Botswana and Senegal, have created similarly ambitious, government-approved plans. In the past, South Africa, which has more HIV-infected people than any other country, resisted public pressure to roll out full AIDS treatment in public hospitals and clinics. But the South African government recently named Mr. Clinton's AIDS Initiative as its main advisory group on HIV treatment, and the Clinton team has helped draft a detailed operational plan for treating AIDS patients that the cabinet is expected to approve shortly. To pay for the drugs, and for the necessary improvements in the countries' tattered health systems, Mr. Clinton has secured partial funding by personally lobbying leaders of rich nations, such as Ireland and Canada. Ireland has committed €50 million ($58.3 million) over five years, mainly to Mozambique. Canada hasn't yet finalized its donation, but it will be in the "tens of millions," according to a senior government official there. The money will go directly to the governments of the countries that Mr. Clinton's team is assisting. "All I do is procure," Mr. Clinton said in an interview, "I don't receive." Mr. Clinton has also raised more than $1 million from private sources.